✦ LIBER ✦

Immunoassays of urokinase (uPA) and its type-1 inhibitor (PAI-1) in detergent extracts of breast cancer tissue

✍ Scribed by A.N Pedersen; H.T Mouridsen; D.Y Tenney; N Brünner

Book ID: 117659971
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 241 KB
Volume: 39
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(03)00025-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic value of urokinase-type plasm

Prognostic value of urokinase-type plasminogen activator (UPA) and its inhibitor PAI-1 in breast cancer

✍ Schmitt, M.; Jänicke, F.; Thomssen, C.; Pache, L.; Bläser, J.; Oppelt, P.; Tsche 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Prognostic significance of urokinase pla

Prognostic significance of urokinase plasminogen activator (uPA) and its inhibitor (PAI-1) in breast cancer

✍ D Vrbanec; S Jelisavac-Cosic; J Jakic-Razumovic; E Mustac; I Kuzmic-Prusac 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 331 KB

Tissue extraction procedures for investi

Tissue extraction procedures for investigation of urokinase plasminogen activator (uPA) and its inhibitors PAI-1 and PAI-2 in human breast carcinomas

✍ F. Descotes; G. Ville; J.Y. Bobin; Y. Barbier; S. Saez 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 982 KB

Prognostic impact of urokinase-type plas

Prognostic impact of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) in cytosols and pellet extracts derived from 892 breast cancer patients

✍ de Witte, J H; Sweep, C G J; Klijn, J G M; Grebenschikov, N; Peters, H A; Look, 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 128 KB

ELISA for complexes of urokinase-type an

ELISA for complexes of urokinase-type and tissue-type plasminogen activators with their type-1 inhibitor (uPA∼PAI-1 and tPA∼PAI-1)

✍ Nicolai Grebenschikov; Fred Sweep; Anneke Geurts; Peter Andreasen; Hans De Witte 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 125 KB 👁 1 views

An ELISA has been developed for the assessment of complexes between the urokinase-type (uPA) and the tissuetype plasminogen (tPA) activators with their inhibitor type-1 (PAI-1) in cell-culture medium and cytosolic extracts of breast tumours. The ''4-stage/2-site'' ELISA involves 2 polyclonal antibod

Combination of urokinase-type plasminoge

Combination of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) has not only prognostic but also predictive impact in primary breast cancer

✍ N. Harbeck; R. Kates; M. Look; C. Thomssen; F. Jänicke; J.G.M. Klijn; M. Kiechle 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 197 KB